CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 136 filers reported holding CASTLE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,172,188 | +23.1% | 602,261 | +0.0% | 0.28% | +29.1% |
Q2 2023 | $8,262,239 | -37.0% | 602,204 | +4.4% | 0.22% | -37.9% |
Q1 2023 | $13,109,849 | +1.1% | 577,018 | +4.7% | 0.35% | +1.7% |
Q4 2022 | $12,972,776 | -14.2% | 551,095 | -5.0% | 0.35% | -18.9% |
Q3 2022 | $15,125,000 | +19.0% | 579,944 | +0.2% | 0.43% | +24.7% |
Q2 2022 | $12,708,000 | -30.8% | 578,933 | +41.5% | 0.34% | -18.5% |
Q1 2022 | $18,358,000 | +21.5% | 409,232 | +16.1% | 0.42% | +37.9% |
Q4 2021 | $15,109,000 | – | 352,441 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |